Cargando…

Green Constant-wavelength Concurrent Selective Fluorescence Method for Assay of Ibuprofen and Chlorzoxazone in Presence of Chlorzoxazone Degradation Product

Lower back pain is a universal dilemma leaving a negative effect on both health and life quality. It was found that a fixed dose combination of chlorzoxazone and ibuprofen gave a higher efficiency than analgesic alone in treatment of acute lower back pain. Based on the significant benefit of that co...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdallah, Nora A., Fathy, Mona E., Tolba, Manar M., El-Brashy, Amina M., Ibrahim, Fawzia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361857/
https://www.ncbi.nlm.nih.gov/pubmed/36809413
http://dx.doi.org/10.1007/s10895-023-03175-6
_version_ 1785076300742918144
author Abdallah, Nora A.
Fathy, Mona E.
Tolba, Manar M.
El-Brashy, Amina M.
Ibrahim, Fawzia A.
author_facet Abdallah, Nora A.
Fathy, Mona E.
Tolba, Manar M.
El-Brashy, Amina M.
Ibrahim, Fawzia A.
author_sort Abdallah, Nora A.
collection PubMed
description Lower back pain is a universal dilemma leaving a negative effect on both health and life quality. It was found that a fixed dose combination of chlorzoxazone and ibuprofen gave a higher efficiency than analgesic alone in treatment of acute lower back pain. Based on the significant benefit of that combination, a green, sensitive, rapid, direct, and cost-effective method is created for concurrent determination of ibuprofen and chlorzoxazone in presence of 2-amino para chlorophenol (a synthetic precursor and potential impurity of chlorzoxazone) adopting the synchronous spectrofluorimetric technique. Synchronous spectrofluorimetric technique is adopted to avoid the highly overlapped native spectra of both drugs. The synchronous spectrofluorometric method was applied at Δλ = 50 nm, ibuprofen was measured at 227 nm while chlorzoxazone was measured at 282 nm with no hindering from one to another. The various experimental variables affecting the performance of the suggested technique were explored and adjusted. The suggested technique showed good linearity from 0.02 to 0.6 and 0.1 to 5.0 µg/mL for ibuprofen and chlorzoxazone, respectively. The produced detection limits were 0.27 × 10(–3) and 0.03, while the quantitation limits were 0.82 × 10(–3) and 0.09 µg/mL for ibuprofen and chlorzoxazone, respectively. The suggested approach was successfully applied for the analysis of the studied drugs in the synthetic mixture, different pharmaceutical preparations, and spiked human plasma. The suggested technique was validated with respect to the International Council of Harmonization (ICH) recommendations. The suggested technique was found to be simpler and greener with lower cost compared to the earlier reported methods which required complicated techniques, longer time of analysis, and less safe solvents and reagents. Green profile assessment for the developed method compared with the reported spectrofluorometric method was performed using four assessment tools. These tools confirmed that the recommended technique attained the most possible green parameters, so it could be used as a greener option in routine quality control for analyzing the two drugs in genuine form and pharmaceutical preparations.
format Online
Article
Text
id pubmed-10361857
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-103618572023-07-23 Green Constant-wavelength Concurrent Selective Fluorescence Method for Assay of Ibuprofen and Chlorzoxazone in Presence of Chlorzoxazone Degradation Product Abdallah, Nora A. Fathy, Mona E. Tolba, Manar M. El-Brashy, Amina M. Ibrahim, Fawzia A. J Fluoresc Research Lower back pain is a universal dilemma leaving a negative effect on both health and life quality. It was found that a fixed dose combination of chlorzoxazone and ibuprofen gave a higher efficiency than analgesic alone in treatment of acute lower back pain. Based on the significant benefit of that combination, a green, sensitive, rapid, direct, and cost-effective method is created for concurrent determination of ibuprofen and chlorzoxazone in presence of 2-amino para chlorophenol (a synthetic precursor and potential impurity of chlorzoxazone) adopting the synchronous spectrofluorimetric technique. Synchronous spectrofluorimetric technique is adopted to avoid the highly overlapped native spectra of both drugs. The synchronous spectrofluorometric method was applied at Δλ = 50 nm, ibuprofen was measured at 227 nm while chlorzoxazone was measured at 282 nm with no hindering from one to another. The various experimental variables affecting the performance of the suggested technique were explored and adjusted. The suggested technique showed good linearity from 0.02 to 0.6 and 0.1 to 5.0 µg/mL for ibuprofen and chlorzoxazone, respectively. The produced detection limits were 0.27 × 10(–3) and 0.03, while the quantitation limits were 0.82 × 10(–3) and 0.09 µg/mL for ibuprofen and chlorzoxazone, respectively. The suggested approach was successfully applied for the analysis of the studied drugs in the synthetic mixture, different pharmaceutical preparations, and spiked human plasma. The suggested technique was validated with respect to the International Council of Harmonization (ICH) recommendations. The suggested technique was found to be simpler and greener with lower cost compared to the earlier reported methods which required complicated techniques, longer time of analysis, and less safe solvents and reagents. Green profile assessment for the developed method compared with the reported spectrofluorometric method was performed using four assessment tools. These tools confirmed that the recommended technique attained the most possible green parameters, so it could be used as a greener option in routine quality control for analyzing the two drugs in genuine form and pharmaceutical preparations. Springer US 2023-02-21 2023 /pmc/articles/PMC10361857/ /pubmed/36809413 http://dx.doi.org/10.1007/s10895-023-03175-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Abdallah, Nora A.
Fathy, Mona E.
Tolba, Manar M.
El-Brashy, Amina M.
Ibrahim, Fawzia A.
Green Constant-wavelength Concurrent Selective Fluorescence Method for Assay of Ibuprofen and Chlorzoxazone in Presence of Chlorzoxazone Degradation Product
title Green Constant-wavelength Concurrent Selective Fluorescence Method for Assay of Ibuprofen and Chlorzoxazone in Presence of Chlorzoxazone Degradation Product
title_full Green Constant-wavelength Concurrent Selective Fluorescence Method for Assay of Ibuprofen and Chlorzoxazone in Presence of Chlorzoxazone Degradation Product
title_fullStr Green Constant-wavelength Concurrent Selective Fluorescence Method for Assay of Ibuprofen and Chlorzoxazone in Presence of Chlorzoxazone Degradation Product
title_full_unstemmed Green Constant-wavelength Concurrent Selective Fluorescence Method for Assay of Ibuprofen and Chlorzoxazone in Presence of Chlorzoxazone Degradation Product
title_short Green Constant-wavelength Concurrent Selective Fluorescence Method for Assay of Ibuprofen and Chlorzoxazone in Presence of Chlorzoxazone Degradation Product
title_sort green constant-wavelength concurrent selective fluorescence method for assay of ibuprofen and chlorzoxazone in presence of chlorzoxazone degradation product
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361857/
https://www.ncbi.nlm.nih.gov/pubmed/36809413
http://dx.doi.org/10.1007/s10895-023-03175-6
work_keys_str_mv AT abdallahnoraa greenconstantwavelengthconcurrentselectivefluorescencemethodforassayofibuprofenandchlorzoxazoneinpresenceofchlorzoxazonedegradationproduct
AT fathymonae greenconstantwavelengthconcurrentselectivefluorescencemethodforassayofibuprofenandchlorzoxazoneinpresenceofchlorzoxazonedegradationproduct
AT tolbamanarm greenconstantwavelengthconcurrentselectivefluorescencemethodforassayofibuprofenandchlorzoxazoneinpresenceofchlorzoxazonedegradationproduct
AT elbrashyaminam greenconstantwavelengthconcurrentselectivefluorescencemethodforassayofibuprofenandchlorzoxazoneinpresenceofchlorzoxazonedegradationproduct
AT ibrahimfawziaa greenconstantwavelengthconcurrentselectivefluorescencemethodforassayofibuprofenandchlorzoxazoneinpresenceofchlorzoxazonedegradationproduct